EnCoRe MoMS:Engaging Communities to Reduce Morbidity From Maternal Sepsis

Sponsor
Columbia University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT06148532
Collaborator
Northern Manhattan Perinatal Partnership (Other), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
400,000
1
41.2
9716.7

Study Details

Study Description

Brief Summary

Sepsis is the second leading cause of maternal death in the U.S. For racial and ethnic minoritized birthing people, especially those who are Black, living in poverty, and from underserved communities, labor and postpartum are particularly vulnerable risk periods. The goal of this multi-center, multidisciplinary observational study is to optimize risk prediction accounting for the social determinants of health, and establish a novel maternal care continuity model to reduce sepsis- related death and disability and increase maternal health equity.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Maternal sepsis is the second leading cause of maternal death, major cause of morbidity, and preventable in most cases. EnCoRe MoMS: Engaging Communities to Reduce Morbidity from Maternal Sepsis will (Aim 2) Develop algorithms to optimize prediction of sepsis around delivery and postpartum.

    In the UG3 phase, robust community engagement and research infrastructures were established to: Aim 2a. Create a rich electronic health records (EHR) database from the Perinatal Research Consortium (PRC). Aim 2b. Collate neighborhood-level datasets characterizing social determinants of health (SDOH)

    In the UH3 phase, the investigators will Aim 2c. Harmonize patient-level EHR and neighborhood-level SDOH datasets and use machine learning models to analyze the individual and joint contributions of patient and neighborhood factors to optimize sepsis risk prediction within the PRC sample.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    400000 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Retrospective
    Official Title:
    EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis
    Actual Study Start Date :
    Apr 26, 2023
    Anticipated Primary Completion Date :
    Aug 31, 2025
    Anticipated Study Completion Date :
    Sep 30, 2026

    Arms and Interventions

    Arm Intervention/Treatment
    PRC Database

    EHR records for hospital delivery admissions and postpartum readmissions obtained from Perinatal Research Consortium (PRC) sites to be harmonized with SDoH data and analyze to optimize sepsis risk prediction.

    Outcome Measures

    Primary Outcome Measures

    1. Maternal sepsis risk [Delivery hospitalization through 8 weeks postpartum]

      Sepsis as evaluated by the following scoring systems: Sepsis-2 (proven or suspected infection in combination with at least two systemic inflammatory response syndrome criteria); Sepsis-3 (organ dysfunction as defined by an acute change in total organ dysfunction score within 24 hours of suspected infection); and Center for Disease Control (CDC) Sepsis (presumed infection and organ dysfunction based on CDC criteria).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Be 18 years or older

    • Delivery admission (and) postpartum readmission at one of the Perinatal Research Consortium sites 2014-2021

    Exclusion Criteria:
    • Under 18 years old

    • Delivery admission (and) postpartum readmission at hospital that is not in the Perinatal Research Consortium

    • Delivery admission before 2014 or after 2021

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Columbia Unviersity Medical Center New York New York United States 10032

    Sponsors and Collaborators

    • Columbia University
    • Northern Manhattan Perinatal Partnership
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    Investigators

    • Principal Investigator: Uma Reddy, MD, Columbia University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Uma Reddy, Professor of Obstetrics and Gynecology, Columbia University
    ClinicalTrials.gov Identifier:
    NCT06148532
    Other Study ID Numbers:
    • AAAU3697 - Aim 2
    • 1UG3HD111247
    First Posted:
    Nov 28, 2023
    Last Update Posted:
    Nov 28, 2023
    Last Verified:
    Nov 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Uma Reddy, Professor of Obstetrics and Gynecology, Columbia University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 28, 2023